ArticleFrontiers in immunology2025
Associations between functional autoantibodies targeting GPCRs, antinuclear antibodies, and inflammatory cytokines TNF-α: a cross-sectional study of 19,810 individuals.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Functional autoantibodies targeting G protein-coupled receptors (GPCR-AAbs) have increasingly been implicated in autoimmune and inflammatory diseases. However, their relationships with established autoimmune biomarkers, such as antinuclear antibodies (ANA), and key inflammatory cytokines remain insufficiently understood. This study aimed to investigate the associations between different functional GPCR-AAbs, ANA positivity, and inflammatory cytokines, with a particular focus on potential sex-specific effects. Methods: We conducted a cross-sectional analysis of 19,810 individuals from a large clinic-based cohort. Serum concentrations of functional GPCR-AAbs (Igβ1AR-AAb, Igβ2AR-AAb, IgM3MR-AAb, IgM4MR-AAb, IgETAR-AAb, and IgAT1R-AAb), ANA titers, and the inflammatory cytokine tumor necrosis factor-α (TNF-α) were measured. Multivariable regression models were applied to assess associations between GPCR-AAbs, ANA positivity, and TNF-α levels, adjusting for demographic and clinical covariates, including age. Sex-stratified analyses were performed. Results: Multiple GPCR-AAbs were significantly associated with ANA positivity, including Igβ1AR-AAb, Igβ2AR-AAb, IgM3MR-AAb, IgM4MR-AAb, IgETAR-AAb, and IgAT1R-AAb. These associations remained robust after adjustment for age and were more pronounced in females. In women, IgM4MR-AAb levels were independently associated with higher TNF-α concentrations (standardized coefficient = 0.28, Discussion: This large-scale cross-sectional study identifies a selective inflammatory axis linking ANA, TNF-α, and functional GPCR-AAbs-particularly M4 muscarinic receptor autoantibodies-in a sex-specific manner. These findings suggest that GPCR-AAbs may complement ANA as early biomarkers of immune dysregulation and provide novel mechanistic insights into autoimmune activation. GPCR-AAbs may hold clinical relevance for risk stratification and therapeutic targeting in autoimmune diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.